Clinical trial
A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a…
NCT00234988 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00234988 |
|---|---|
| Title | A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects. |
| Official title | Safety and Weight Reduction of Sibutramine in the Treatment of Thai Obese and Overweight Subjects |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | sibutramine hydochloride monohydrate |
| Enrollment | 93 |
| Start date | Jun 1, 2004 |
| Primary completion | Jan 1, 2006 |
| First posted | Oct 10, 2005 |
| Last update posted | Jul 15, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: